Unknown

Dataset Information

0

Dopamine agonists for preventing ovarian hyperstimulation syndrome.

ABSTRACT:

SUBMITTER: Tang H 

PROVIDER: S-EPMC6465062 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis.
| S-EPMC4707491 | biostudies-literature
Unknown Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.
| S-EPMC3727944 | biostudies-literature
Unknown Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome.
| S-EPMC4397691 | biostudies-literature
Unknown Rare genetic variants potentially involved in ovarian hyperstimulation syndrome.
| S-EPMC6439123 | biostudies-literature
Unknown Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma.
| S-EPMC2777809 | biostudies-literature
Unknown A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.
| S-EPMC5482139 | biostudies-literature
Transcriptomics High throughput sequencing data of ovarian hyperstimulation syndrome (OHSS) mouse model
2021-09-05 | GSE183346 | GEO
Unknown Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
| S-EPMC8041489 | biostudies-literature
Unknown The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial.
| S-EPMC2839910 | biostudies-literature
Unknown Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.
| S-EPMC7851086 | biostudies-literature